Back to search

Article

Predicting amyloid-PET positivity and clinical conversion in APOE ε3/ε3 non-demented individuals with multimodal factors

2024-05-22

Abstract excerpt

The most typical pathological change in Alzheimer’s disease (AD) is the aggregated deposition of amyloid-β (Aβ). APOE ε3/ε3 is the most prevalent genotype in the AD population. Individuals with amyloid-PET (Aβ-PET) positivity (+) and disease progression may not be a minority in the APOE ε3/ε3 non-demented population. This study searched for accessible and available clinical models that can predict Aβ-PET (+), and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
03db7a7e-21e1-518e-9226-16399038ce45
DOI
10.22541/au.171634433.35050622/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predicting amyloid-PET positivity and clinical conversion in APOE ε3/ε3 non-demented individuals with multimodal factorsDOI 10.22541/au.171634433.35050622/v1
Risk Factors Predicting Amyloid PET Positivity in Patients with Mild Cognitive Impairment and Apolipoprotein E ɛ3/ɛ3 Genotypes.Semantic proximity
Detection of tau-PET positivity in clinically diagnosed mild cognitive impairment with multidimensional features.Semantic proximity
Analyzing the effect of APOE on Alzheimer's disease progression using an event-based model for stratified populations.Semantic proximity
Promising clinical tools for specific Alzheimer disease diagnosis from plasma pTau217 and ApoE genotype in a cognitive disorder unitSemantic proximity
A Novel Ensemble-Based Machine Learning Algorithm To Predict The Conversion From Mild Cognitive Impairment To Alzheimer’s Disease Using Socio-demographic Characteristics, Clinical Information And Neuropsychological MeasuresSemantic proximity
Voxel-wise insights into early Alzheimer's disease pathology progression: the association with APOE and memory decline.Semantic proximity
Predicting 24-Month MCI-to-Alzheimer’s Conversion Using Routine Clinical Assessments Without Neuroimaging or Genetic TestingSemantic proximity
Development of a prediction model of conversion to Alzheimer’s disease in subjects with mild cognitive impairment: the statistical analysis plan of the INTERCEPTOR projectSemantic proximity
Radiomics Features of FDG PET Images Predict ApoE4 and may Provide Clues for Further Studies on Alzheimer’s DiseaseSemantic proximity
Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.Semantic proximity
Accurate Prediction of Conversion to Alzheimer’s Disease using Imaging, Genetic, and Neuropsychological BiomarkersSemantic proximity
Apolipoprotein E genotypes and amyloid burden associated with cognitive decline in non-demented Parkinson's disease patients: A preliminary analysis.Semantic proximity
Select a neighboring publication to make it the new centre.